Valuation: Highnoon Laboratories Limited

Market Cap 49.32B 178M 159M 147M 133M 251M 16.82B 254M 1.76B 692M 8.84B 669M 655M 28.18B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 49.32B 178M 159M 147M 133M 251M 16.82B 254M 1.76B 692M 8.84B 669M 655M 28.18B EV / Sales 2026 *
1.62x
EV / Sales 2027 * 1.44x
Free-Float
50.02%
Yield 2026 *
4.83%
Yield 2027 * 5.59%
1 day-0.70%
1 week+1.33%
Current month-0.22%
1 month-0.81%
3 months-5.83%
6 months-10.12%
Current year-8.96%
1 week 915.63
Extreme 915.63
980
1 month 910
Extreme 910
980
Current year 755.56
Extreme 755.56
1,101
1 year 755.56
Extreme 755.56
1,224
3 years 412
Extreme 412
1,241
5 years 322.1
Extreme 322.1
1,241
10 years 127.86
Extreme 127.855793
1,241
Manager TitleAgeSince
Chief Executive Officer - 2015-03-31
Chief Executive Officer 63 1995-12-31
Director of Finance/CFO - 2020-03-31
Director TitleAgeSince
Chairman - 2012-09-06
Chairman - -
Director/Board Member 36 -
Change 5-day change 1-year change 3-year change Capi.($)
-0.70%+1.33%-18.98%+124.18% 178M
+1.73%+5.13%+58.93%+117.36% 1,133B
+1.44%+1.52%+34.34%+68.48% 621B
-0.58%+0.47%+23.08%+94.76% 503B
-0.68%+2.00%+38.07%+63.04% 379B
+1.17%+1.70%+71.06%+45.98% 370B
+0.88%+1.43%+21.78%+51.12% 292B
+1.36%-0.02%+1.24%+25.70% 262B
+0.95%+2.87%+45.56%+57.22% 237B
+0.76%+0.02%+23.77%+97.39% 190B
Average +0.63%+3.05%+29.89%+74.52% 398.82B
Weighted average by Cap. +0.88%+3.73%+40.73%+79.71%

Financials

2026 *2027 *
Net sales 30.4B 110M 97.91M 90.65M 82.04M 155M 10.37B 156M 1.09B 426M 5.45B 412M 404M 17.37B 34.16B 123M 110M 102M 92.2M 174M 11.65B 176M 1.22B 479M 6.13B 463M 454M 19.52B
Net income - -
Net Debt - -
Projected Income Statement - Annual - Highnoon Laboratories Limited
Logo Highnoon Laboratories Limited
Highnoon Laboratories Limited is a Pakistan-based company that is engaged in the manufacturing, importing, selling, and marketing of pharmaceutical and related consumer products. Its product categories include cardiology, metabolic, gastroenterology, musculoskeletal, anti-infective, obstetrics and gynecology, pediatrics, allergy, respiratory, and urology. Its cardiology products include Cuziper, Hitica, Apiban, Misar, and Herbesser. Its metabolic products include Daploz, Tagip, Diajard, and Nylomet. Its gastroenterology products include Rabecid, Racedo, Skilax, and Fosbu. Its musculoskeletal products include Kydor, Hilin, Airtal, and Tamadol. Its anti-infective products include Evacef, Maxum, Efix, and Cefia. Its obstetrics and gynecology products include Hitase. Its pediatrics product includes Tres Orix Forte. Its allergy products include Leviva and Kestine. Its respiratory products include Combivair Forte, Glynvair, Betatec, Ultivair, and Montit. Its urology products include Prostam.
Employees
2,563
Date Price Change Volume
26-10-21 PKR 930.91 -0.70% 6,252
26-10-20 PKR 937.43 -0.09% 25,037
26-10-19 PKR 938.27 +0.68% 14,495
26-10-16 PKR 931.97 +1.71% 4,414
26-10-15 PKR 916.26 -0.27% 13,991
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
930.91PKR
Average target price
1,121.00PKR
Spread / Average Target
+20.42%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Highnoon Laboratories Limited
  1. Stock Market
  2. Stocks
  3. HINOON Stock